The 2025 reconciliation law imposed new Medicaid and CHIP eligibility restrictions for many lawfully present immigrants, with an effective date of October 1, 2026. CMS has issued implementation guidance addressing how states should apply these restrictions. The brief examines operational issues states will face in implementing the new eligibility rules and the impact on affected immigrant populations. The changes directly affect state eligibility systems, enrollment processes, and coverage for lawfully present immigrants who previously qualified for Medicaid and CHIP.
Why it mattersState Medicaid agencies must reconfigure eligibility systems, update enrollment procedures, and prepare to disenroll or deny coverage to lawfully present immigrants by October 1, 2026, requiring immediate operational planning and stakeholder communication.
CHIP
The Medicaid and CHIP Payment and Access Commission (MACPAC) submitted comments to CMS on a proposed rule that would revise the indirect hold harmless threshold — the safe harbor — used to determine whether health care-related taxes impermissibly shift Medicaid costs to the federal government. The proposed rule changes how CMS evaluates whether provider tax arrangements violate federal Medicaid financing requirements. This affects state Medicaid financing strategies that rely on provider taxes to fund non-federal share of payments, a common mechanism used by states to draw down federal matching funds.
Why it mattersProvider tax safe harbor thresholds directly determine which state Medicaid financing arrangements CMS will approve, affecting billions in federal matching payments and state budget flexibility.
Finance
The American Hospital Association submitted comments September 21 on CMS's proposed rule implementing Medicaid provider tax changes from the July 2025 reconciliation law. Beginning in fiscal year 2027, states cannot raise the provider tax indirect hold harmless threshold above the rate in place at enactment; for expansion states, the hospital threshold decreases 0.5 percentage points annually starting FY 2028. AHA opposes CMS's proposed retrospective reconciliation requirement, arguing it creates unpredictability for state Medicaid programs and adds administrative burden. AHA recommends CMS use prospective estimates for ongoing compliance monitoring and limit retrospective calculations to the one-time statutory threshold determination.
Why it mattersThe retrospective reconciliation approach could force states to repay federal Medicaid matching funds after-the-fact based on actual tax collections, introducing budget uncertainty and potentially destabilizing hospital financing arrangements that rely on provider tax revenue.
Finance
The Trump administration has released a plan intended to reduce drug costs for Medicaid beneficiaries, but the policy contains an exception that may exempt certain medications from cost controls. The exception could allow manufacturers to avoid pricing restrictions that would otherwise apply to Medicaid drugs. The policy's structure may create differential treatment across drug classes, with potential financial implications for state Medicaid programs and health plans managing pharmacy benefits. Details on implementation timeline and which specific medications qualify for the exception remain to be clarified.
Why it mattersState Medicaid agencies and managed care plans need to assess whether this exception will increase pharmacy spending for drugs that would otherwise be subject to cost controls, affecting capitation rates and budget projections.
Pharmacy · Managed Care · Finance
The Trump administration announced Tuesday it will terminate Affordable Care Act marketplace coverage for approximately 750,000 enrollees identified as fraudulent, according to Vice President Vance. The administration estimates the cancellations will save $2.2 billion in federal subsidies. CMS Administrator Dr. Mehmet Oz stated the terminated enrollments represent non-existent individuals. The announcement did not specify an effective date for the terminations or detail the criteria used to identify fraudulent enrollment.
Why it mattersLarge-scale ACA marketplace terminations could shift uninsured or newly eligible individuals to Medicaid in states with expansion, affecting enrollment volumes and state budget projections.
Finance
An influential Republican health policy expert is defending proposed $1 trillion cuts to Medicaid spending and identifying additional policy targets for future action. The article does not specify which Republican expert or what legislative vehicle would implement these cuts. The timing and likelihood of enactment are unclear given the need for congressional approval. For state Medicaid agencies and managed care organizations, these proposals signal continued federal-level debate over Medicaid financing that could affect coverage levels, eligibility, and capitation payments if enacted.
Why it mattersSustained advocacy for major federal Medicaid spending reductions from influential Republican policy voices could foreshadow future legislative proposals affecting state program funding, eligibility, and MCO capitation rates.
Finance · Managed Care
The federal government has announced pricing agreements with 26 pharmaceutical manufacturers. These agreements could constrain future policy options to reduce drug spending across federal programs. The specific terms, enforcement mechanisms, and timeline for these agreements have not been publicly disclosed. The agreements may affect Medicaid programs' ability to pursue independent drug cost containment strategies, particularly for states that rely on federal negotiations or supplemental rebate programs tied to federal pricing benchmarks.
Why it mattersStates may face limited flexibility in negotiating supplemental rebates or implementing formulary restrictions if federal pricing agreements preempt or conflict with state-level cost containment authority.
Pharmacy · Managed Care · Finance
The White House has published a Fraud Ledger documenting fraud, waste, and corruption identified by a presidential task force established by executive order in March 2025. The task force is chaired by the Vice President and includes representatives from 11 federal agencies. The ledger serves as a public record of enforcement and recovery actions across federal programs. The article itself fact-checks the ledger's claims, though the specific findings and their application to Medicaid programs are not detailed in the excerpt provided.
Why it mattersA White House-led fraud task force with multi-agency participation signals heightened federal enforcement scrutiny that could affect Medicaid program integrity expectations, audit activity, and recovery targets for states and managed care plans.
Managed Care · Finance
CMS announced over $45 million in federal funding to support rural hospitals in Missouri for facility upgrades, telehealth services including psychiatric and maternal care consultations, and emergency medical services workforce training. The awards are part of broader federal rural health investment programs. Implementation timelines and specific facility allocations were not detailed in the announcement. The funding addresses critical access hospital infrastructure needs and care access gaps in rural Missouri communities.
Why it mattersState Medicaid agencies and managed care plans in Missouri will need to coordinate with rural hospitals receiving this infrastructure and telehealth funding to ensure new services integrate with Medicaid coverage and reimbursement arrangements, particularly for behavioral health and maternal care telehealth consultations.
Behavioral Health · Maternal
A proposed CMS rule affecting Medicare-participating skilled nursing facilities is under review by the Office of Management and Budget. The proposal appears aligned with prior CMS deregulatory efforts under the Trump administration. OMB review is the final step before a proposed rule is published in the Federal Register, after which a public comment period typically follows. The timing and scope of the proposal remain uncertain pending OMB clearance.
Why it mattersChanges to SNF regulatory requirements could affect dual-eligible beneficiaries and state Medicaid agencies that rely on Medicare participation standards for nursing facility oversight and rate-setting.
LTSS
CMS proposed the Regulatory Alignment for Predictable and Immediate Device (RAPID) pathway to coordinate FDA device approval with Medicare coverage decisions, compressing a typical five-year lag to 60-90 days. The pathway synchronizes regulatory approval and coverage determination processes from the outset. Manufacturers of breakthrough devices would participate in joint FDA-CMS reviews. This matters for Medicaid managed care organizations and state agencies because accelerated Medicare coverage pathways often influence state Medicaid coverage decisions and MCO formulary policies for medical devices and durable medical equipment.
Why it mattersFaster Medicare coverage for breakthrough devices typically pressures state Medicaid programs and MCOs to update coverage policies and prior authorization protocols within months rather than years.
Managed Care
The CDC's National Center for Health Statistics reported on September 22, 2026, that suicide rose to the 10th leading cause of death in the United States in 2024, despite a decline in the absolute number of suicide deaths from the prior year. The final mortality data comes from the CDC's annual leading causes of death report. The shift in ranking reflects changes in other causes of death rather than an increase in suicide mortality. For Medicaid managed care organizations and state agencies, suicide mortality trends directly affect behavioral health network adequacy requirements, crisis intervention program design, and performance measure benchmarks tied to behavioral health access and outcomes.
Why it mattersSuicide as a top-10 cause of death elevates pressure on Medicaid MCOs and state agencies to expand behavioral health crisis services, strengthen network adequacy for mental health providers, and meet quality measures tied to suicide screening and prevention.
Behavioral Health
Analysis finds out-of-network emergency care spending has fallen since the No Surprises Act took effect in 2022, contrary to debate focused on arbitration costs. The law protects patients from surprise billing for emergency services they cannot choose. For Medicaid managed care plans with emergency coverage obligations, this federal benchmark on balance billing and dispute resolution may inform state approaches to network adequacy and emergency access requirements, particularly where Medicaid enrollees receive emergency care at out-of-network facilities.
Why it mattersThe spending decline demonstrates the No Surprises Act's effectiveness at controlling emergency care costs, potentially providing a model for states addressing Medicaid managed care network adequacy and emergency service payment disputes.
Managed Care
